PD Dr. rer. nat. Adelheid Cerwenka

PD Dr. rer. nat. Adelheid Cerwenka

PD Dr. rer. nat. Adelheid Cerwenka

Position:

Group-Leader

Phone:

+49 (0)6221-42-4480

Fax:

+49 (0)6221-42-3755

Building:

Main Building

Room:

H2.07.074

Curriculum Vitae

Education:

1986 - 1991
Diploma in Pharmacy, University of Vienna, Austria, Faculty of Natural Sciences

1991 - 1995
Dissertation, Vienna International Cooperation Center, Institute of Immunology, University of Vienna, Austria, at Prof. Walter Knapp and Doz. Wolfgang Holter

1996 – 1998
Postdoc, University of California, San Diego, CA, USA until 06/1996 and at the Trudeau Institute, NY, USA, at Prof. Richard W. Dutton and Susan L. Swain

11/1998 – 9/2001
Postdoc, DNAX Research Institute, Palo Alto, CA, USA and University of California, San Francisco, USA at Prof. Lewis L. Lanier

10/2001 – 3/2003
Head of Laboratory, Division of Autoimmune Diseases, Novartis Research Institute, Vienna, Austria, Molecular Immunology: “Target Identification and Validation”

4/2003 – today
Head of the independent Boveri-Group “Innate Immunity” at the German Cancer Research Center, Heidelberg, Germany

7/2007
Venia Legendi for Immunology, University of Heidelberg, Faculty of Medicine, Heidelberg, Germany



Awards and fellowships:

1986 “Golden Ring“ for the best graduation diploma „summa cum laude“

1996 Schrödinger-Postdoc-Grant for 2 Years by the Austrian Government

2001 Huang-Foundation-Award of the American Association of Immunologists

2005 MicroRNA and Cancer: Award-Winning Research Idea at the Helmholtz-Idea-Contest

2006 FEMtech Expert of the Month July, selected by an International Jury, Initiative of the Austrian Research Fonds

2009 Georges-Köhler Award 2009 by DGfI



Memberships:

DGfI, Deutsche Gesellschaft für Immunologie

Society for Natural Immunity



Funding:

9/2005-9/2007 Helmholtz-Association-Award for the Research Concept: “microRNA and Cancer“ together with Dr. Michael Boutros, Total Sum: 100.000€

6/2005-1/2009 German-Israeli Cooperation (DKFZ-MOST)

6/2010-6/2013 Fortsetzungsprojekt: German-Israeli Cooperation (DKFZ-MOST)

10/2004-4/2009 Deutsche Jose Carreras Stiftung Leukämie-Stiftung e.V. Total Sum: 274.500 € (cost neutral prolongation was applied)

7/2004-7/2009 Marie Curie Excellence Grant
Total Sum: 1.358.142 €

06/2010-06/2013 Deutsche Krebshilfe, Total Sum 248.400 €



Management training:

Management Course “Leading at the front line”, Novartis training program, 2002



Patent:

Adelheid Cerwenka, Frank Kalthoff, William Phares: Organic compounds. Novartis Forschungsinstitut, Vienna, WO03/008576. PCT/EP02/079

to top